Dr Reddy's, Zydus Wellness, Cadila and Wipro among top stocks to track

Here's a look at the top stocks that may remain in focus today -

Markets, Stocks, Shares
A share broker monitors market fluctuation
SI Reporter New Delhi
Last Updated : Dec 12 2018 | 8:52 AM IST
Markets are likely to remain range-bound in trade today as they assess and interpret the outcome of assembly polls announced Tuesday. However, bank and NBFC stocks are likely to be in focus following the appointment of Shaktikanta Das as the new RBI governor. 

At 08:31 am, the Nifty futures on the Singapore Stock Exchange (SGX) were trading 12 points or 0.11 per cent lower at 10,588, indicating a flat to negative opening for the market. 

Here's a look at the top stocks that may remain in focus today - 

Wipro: The company on Tuesday said it has set up an automotive innovation centre in Detroit, US that will help the IT major deepen its relationship with the Motor City's automotive community. The new centre adds to Wipro's existing footprint in Detroit.

Dr Reddy's: The drug major said it has launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market. Quoting IRI data, Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $492 million for the most recent twelve months ending in October 2018. 

Tata Sponge Iron: The Competition Commission has cleared Tata Sponge Iron's acquisition of steel business of Usha Martin for Rs 43-47 billion.

Reliance Industries: The board of Reliance Jio, a subsidiary of Reliance Industries Limited (RIL), on Tuesday approved a scheme to hive off the fibre and tower businesses into separate companies. Analysts feel this would provide a better leverage to raise funds with support from parent RIL, especially as the fibre business capex would be top loaded.

Zydus Wellness, Cadila: The Competition Commission Tuesday said it has approved Zydus-Cadila's deal to acquire Heinz India consumer wellness business that includes popular brands like Complan and Glucon D.

Indiabulls Ventures: Indiabulls Ventures promoter Sameer Gehlaut and five other promoter entities have settled a Sebi probe into the alleged violation of ‘takeover regulations’ after paying Rs 48 lakh towards settlement fee.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story